search:



Re: Bextra

From: anonymous@obgyn.net
Sat Apr 19 10:26:55 2003


Posted to the ERC Listserve in November 2002 --

According to Medwatch, the FDA and Pharmacia/Pfizer have strengthened the CONTRAINDICATIONS, WARNINGS, and ADVERSE REACTIONS sections of the prescribing information for Bextra (valdecoxib).

In postmarketing experience, rare reports of hypersensitivity reactions (i.e, anaphylatic reactions and angioedema) and skin reactions, including cases of Stevens-Johnson syndrome, toxic epidermal necrolysis, exfoliative dermatitis, and erythema multiforme, have been received. These cases, some of which were serious/life threatening, have occured in patients with and without a history of allergic type reations to sulfonamides.

To read the MedWatch 2002 Bextra safety alert, including links to the "Dear Healthcare Professional" letter and an FDA Talk Paper, go to: http://www.fda.gov/medwatch/SAFETY/2002/safety02.htm#bextra




recommended search...
Google
OBGYN.net forums endometriosis zone Web

use when must restrict search to only the endometriosis forum...
Enter search keywords:
Returns per screen: Require all keywords:
Return to [ endo@obgyn.net ] Technical Problems: webmaster@obgyn.net
Last Updated: Wed Dec 2 03:43:25 2009

Women's Insurance Checklist from Auto Insurance Quote

home | medical professionals | women | industry | forums | international
e-mail | about us | advertising | our sponsors | contact us | disclaimer |

This information is provided for educational purposes only.
Please read the disclaimer. ©1996-2008, all rights reserved.
Do not reproduce without permission of MediSpecialty.com